Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited (India) holds 224 active US FDA Type II Drug Master Files and 87 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 2 active Type IV (excipient) Drug Master Files and is linked to 8 FDA-registered manufacturing sites. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sun Pharmaceutical Industries Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sun-pharmaceutical-industries-limited

Overview

Sun Pharmaceutical Industries Limited is a leading multinational pharmaceutical company based in India. It specializes in a wide range of pharmaceutical formulations and active pharmaceutical ingredients. The company serves customers in over 100 countries and offers a variety of affordable and quality medicines in therapeutic segments such as cardiology, psychiatry, neurology, gastroenterology, and more.

Core services & business areas

API ManufacturingFormulation DevelopmentRegulatory AffairsQuality AssuranceOphthalmic Product DevelopmentDrug Delivery SystemsLicensing and Intellectual Property

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Sun Pharmaceutical Industries Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Sun Pharmaceutical Industries Limited holds 224 active (311 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • TRAMETINIB DIMETHYL SULFOXIDEActive2026-09-30
  • OCTREOTIDE ACETATE USP (DEPOT)Active2026-07-27
  • DEUCRAVACITINIBActive2026-06-25
  • LORLATINIBActive2026-03-06
  • PONATINIB HYDROCHLORIDEActive2026-01-29
  • LEVOTHYROXINE SODIUM USPActive2025-12-31
  • METHYLNALTREXONE BROMIDE USPActive2025-12-24
  • SITAGLIPTIN PHOSPHATE USP (PROCESS II)Active2025-12-19
  • MARIBAVIRActive2025-09-16
  • ISTRADEFYLLINEActive2025-06-30
  • VISMODEGIBActive2025-01-31
  • METFORMIN HYDROCHLORIDE USP (LDMA PROCESS)Active2025-01-31
  • SINCALIDEActive2025-01-16
  • APOMORPHINE HYDROCHLORIDE USPActive2024-12-02
  • COLESTIPOL HYDROCHLORIDE USPActive2024-11-21
  • BUPROPION HYDROCHLORIDE USP (PROCESS-II)Active2024-05-06
  • PALIPERIDONE PALMITATEActive2024-03-29
  • TRIHEPTANOINActive2024-03-29
  • TIOPRONINActive2024-02-01
  • TOLVAPTANActive2024-01-03
  • NITAZOXANIDEActive2023-12-29
  • TAFAMIDISActive2023-12-15
  • SELENIOUS ACIDActive2023-12-04
  • DIVALPROEX SODIUM USP (PROCESS II)Active2023-09-29
  • PRUCALOPRIDE SUCCINATEActive2023-09-28
  • ZIPRASIDONE MESYLATE TRIHYDRATEActive2023-07-19
  • LANREOTIDE ACETATEActive2023-02-02
  • ELAGOLIX SODIUMActive2022-05-11
  • ENZALUTAMIDEActive2022-03-25
  • NALTREXONE HYDROCHLORIDE USP (DIHYDRATE FORM) (PROCESS-II)Active2022-03-17
  • PAZOPANIB HYDROCHLORIDEActive2022-02-14
  • ARIPIPRAZOLE USPActive2022-02-14
  • LIRAGLUTIDEActive2021-12-30
  • NALOXONE HYDROCHLORIDE DIHYDRATE USP (PROCESS II)Active2021-11-19
  • SEMAGLUTIDEActive2021-10-15
  • BOSUTINIBActive2021-08-19
  • AMBRISENTANActive2021-07-22
  • PANTOPRAZOLE SODIUM USP (PROCESS II)Active2021-05-15
  • VALPROIC ACID USP (PROCESS-II)Active2021-03-31
  • TERIPARATIDE USPActive2021-02-22
  • NOREPINEPHRINE BITARTRATE USPActive2021-02-22
  • NILOTINIB BUTANEDISULFONATEActive2020-12-24
  • Tramadol Hydrochloride USP (Process-II)Active2020-04-29
  • LIFITEGRASTActive2020-04-10
  • CETRORELIX ACETATEActive2020-03-27
  • DROXIDOPAActive2019-12-31
  • ALECTINIB HYDROCHLORIDEActive2019-12-16
  • CABOZANTINIB-S-MALATEActive2019-11-06
  • CANAGLIFLOZIN CRYSTALLINEActive2019-09-30
  • BOSENTAN MONOHYDRATEActive2019-09-26

Showing the 50 most relevant of 311 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

Sun Pharmaceutical Industries Limited holds 2 active (2 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • [DL]-POLYLACTIC ACID OR [DL]-PLA-2Active2025-03-26
  • POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA7515)Active2024-03-29

Registered manufacturing sites (8)

Physical sites registered with the US FDA and resolved to Sun Pharmaceutical Industries Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • eu_noncompliance2026-03-30

    EU GMP Statement of Non-Compliance

  • 4832026-02-06

    Procedures not in writing, fully followed

  • 4832025-06-13

    Validation lacking for sterile drug products

  • 4832025-06-13

    Absence of Written Procedures

  • 4832025-06-13

    Prepared for each batch, include complete information

  • 4832025-06-13

    Procedures for sterile drug products

  • 4832025-06-13

    Scientifically sound laboratory controls

  • 4832025-06-13

    Investigations of discrepancies, failures

  • 4832025-06-13

    Cleaning / Sanitizing / Maintenance

  • 4832025-06-13

    Equipment Design, Size and Location

  • warning_letter2024-06-18

    FDA Warning Letter (drug product)

  • recall — Class II2023-05-03

    Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.

  • warning_letter2022-12-15

    FDA Warning Letter (drug product)

  • 4832022-08-12

    Written Procedures Not Followed

  • 4832022-08-12

    Scientifically sound laboratory controls

  • 4832022-08-12

    Complete Test Data

  • 4832022-08-12

    Following/documenting laboratory controls

  • 4832022-08-12

    Approval and review of procedures

  • 4832022-08-12

    Investigations of discrepancies, failures

  • 4832022-05-09

    Equipment Design, Size and Location

  • 4832022-05-09

    Written program not followed

  • 4832022-05-09

    Environmental Monitoring System

  • 4832022-05-09

    Cleaning / Sanitizing / Maintenance

  • 4832022-05-09

    Investigations of discrepancies, failures

  • 4832022-05-09

    Aseptic Processing Area

  • 4832022-05-09

    Scientifically sound laboratory controls

  • 4832022-05-09

    Training , Education , Experience overall

  • 4832022-05-09

    Procedures not in writing, fully followed

  • 4832022-05-09

    Validation lacking for sterile drug products

  • 4832019-12-13

    Scientifically sound laboratory controls

  • 4832019-12-13

    Procedures for sterile drug products

  • 4832019-12-13

    Investigations of discrepancies, failures

  • 4832019-12-13

    Procedures not in writing, fully followed

  • 4832019-12-13

    Control procedures to monitor and validate performance

  • 4832019-12-13

    Environmental Monitoring System

  • 4832019-12-13

    Absence of Written Procedures

  • 4832019-12-13

    Written in-process control procedures

  • 4832019-03-29

    Training , Education , Experience overall

  • 4832019-03-29

    Annual visual exams of drug products

  • 4832019-03-29

    Complete test data included in records

  • 4832019-03-29

    Procedures To Be in Writing

  • 4832019-03-29

    Written procedures not established/followed

  • 4832019-03-29

    Absence of Written Procedures

  • 4832019-03-29

    Establishment of time limitations

  • 4832019-03-29

    Drug product sample

  • 4832019-03-29

    Authority lacking to review records, investigate errors

  • 4832019-03-29

    Procedures not in writing, fully followed

  • 4832019-03-29

    Composite sample top/middle/bottom

  • 4832018-02-23

    Procedures To Be in Writing

  • 4832018-02-23

    Written procedures fail to include

For suppliers

Is this Sun Pharmaceutical Industries Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.